Glucagon-like peptide-1 (GLP-1) receptor agonists are increasingly prescribed for type 2 diabetes and weight management in the UK
Some studies have found that GLP-1 receptor agonist medications can 17: Improve ovulation and menstrual regularity Increase pregnancy rates in certain populations These effects appear to be largely mediated by: Improved insulin sensitivity Reduced androgen levels A more stable metabolic environment Cardiometabolic Health GLP-1 receptor agonists have consistently been shown to improve cardiometabolic risk markers
doi: 10.1007/s13679-014-0129-4
Simple screenings for stroke risk, heart disease, cancer and more to live a longer, fuller life
For the full peptide profile, mechanisms, and research bibliography, see the GHK-Cu peptide page
No Affiliation With Featured Persons: This article references Paige Hathaway as the publicly disclosed founder and brand figure associated with LIV Body, as stated on the brand's own official website